Pharmaceutical Drugs

Research conducted by: RAND Health

All Items (154)

Report

Regulatory cultures and research governance — Mar 1, 2013

This is a comparative study of the practice of those who are subject to regulatory requirements in the health research, medical drugs, environmental and financial sectors conducted to assist understanding of health research governance in the UK.

Report

Economic Effects of Product Liability and Other Litigation Involving the Safety and Effectiveness of Pharmaceuticals — Feb 19, 2013

Opponents of product liability claim that liability reduces product availability, increases prices, and discourages innovation. Supporters claim that liability uncovers information about drug hazards and deters socially undesirable corporate behavior.

Journal Article

What It Will Take to Achieve the As-Yet-Unfulfilled Promises of Health Information Technology — Jan 1, 2013

HIT's disappointing performance primarily stems from sluggish adoption of health IT systems, systems that are not interoperable or easy to use, and failure of providers and institutions to do their part by reengineering care processes.

Journal Article

Racial/Ethnic Disparities in Medicare Part D Experiences — Oct 29, 2012

Quality improvement efforts may be needed to reduce racial/ethnic disparities in beneficiary experience with PD coverage.

Journal Article

Access to and Use of $4 Generic Programs in Medicare — Oct 1, 2012

Although four-dollar programs ($4 per 30-day supply for selected generic drugs) have become important options for seniors to obtain affordable medications, little is known about access to these programs and the characteristics of those who use them.

Journal Article

The Large Social Value Resulting from Use of Statins Warrants Steps to Improve Adherence and Broaden Treatment — Oct 1, 2012

Statins are considered a clinically important breakthrough for the treatment of cardiovascular disease.

News Release

The Illicit Drug Landscape in the U.S and Paths for Future Efforts — Sep 18, 2012

The nature of the American drug problem has changed substantially over the last 20 years. It is now less of a crime problem illustrated by drug market violence and more of a health problem with higher rates of morbidity and mortality, and a criminal justice problem of burdensome incarceration rates.

Report

Insights and Opportunities for Improving U.S. Drug Policy — Sep 18, 2012

The nature of the American drug problem has changed substantially over the last 20 years. It is now less of a crime problem illustrated by drug market violence and more of a health problem with higher rates of morbidity and mortality, and a criminal justice problem of burdensome incarceration rates.

Blog

When Patients Don't Take Their Medicine: What Role Do Doctors Play in Promoting Prescription Adherence? — Aug 29, 2012

Medication non-adherence affects up to 40 percent of older adults, especially those with chronic conditions, and is associated with poor outcomes, more hospitalizations, and higher mortality. A new paradigm that clarifies joint provider–patient responsibility is needed.

Research Brief

When Patients Don't Take Their Medicine: What Role Do Doctors Play in Promoting Prescription Adherence? — Aug 28, 2012

Analyses indicated that although physicians uniformly felt responsible for assessing and promoting adherence to prescriptions, only a minority of them asked detailed questions about adherence.

Report

Negotiating Prices of Antiretroviral Medications for HIV Treatment — Jul 10, 2012

Antiretroviral (ARV) treatment has transformed HIV from a death sentence to a chronic condition, allowing patients to live longer and healthier lives. Options for reducing costs of ARV medications should be explored in order to allow more people to receive treatment.

Blog

Could Liability Concerns Derail Clinical Decision Support? — Jul 6, 2012

Computerized clinical decision support (CDS) systems have been developed to enhance physician decisionmaking and reduce the incidence of avoidable medical errors. Drug-drug interaction warnings are a mainstay of CDS systems, but they give rise to a fundamental problem that limits the utility of the systems to date.

Journal Article

Use of a Computerized Medication Shared Decision Making Tool in Community Mental Health Settings: Impact on Psychotropic Medication Adherence — Jul 1, 2012

This study examined the impact on psychotropic adherence of a decision support center and computerized tool designed to empower and activate consumers prior to an outpatient medication management visit.

Journal Article

Nonmedical Prescription Drug Use Among Injection Drug Users — Jul 1, 2012

This study described the prevalence and risk factors for nonmedical prescription drug use (NMPD) among injection drug users (IDUs) recruited at syringe exchange programs (SEPs) in California.

Report

A New Commercial Model for Big Pharma in the Postblockbuster World — Jun 8, 2012

The pharmaceutical industry can and should reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions.

Project

Medicines as Service May Offer New Commercial Model for Big Pharma — Jun 7, 2012

If the pharmaceutical industry develops innovative and meaningful business models to offer services that improve access and adherence to prescription drugs for common chronic conditions, it can profit far more than by developing more "blockbuster" drugs.

Journal Article

Too Many Alerts, Too Much Liability: Sorting Through the Malpractice Implications of Drug-Drug Interaction Clinical Decision Support — Jun 1, 2012

New electronic clinical decision support (CDS) systems are intended to reduce medical errors but sometimes have the unexpected and perverse effect of overwhelming physicians with potential warnings about trivial events, particularly regarding drug-drug interactions.

Journal Article

Provider Views About Responsibility for Medication Adherence and Content of Physician-Older Patient Discussions — Jun 1, 2012

This article explores provider opinions about responsibility for medication adherence and examine physician--patient interactions to illustrate how adherence discussions are initiated.

Commentary

Prescription Drug Shortages: Reconsidering the Role of Medicare Payment Policies — May 29, 2012

The focus on the MMA as a primary cause of prescription drug shortages is premature and may deflect attention away from identifying other potentially more important causes, write Mireille Jacobson, Abby Alpert, and Fabian Duarte.

News Release

Probiotics Can Reduce Risk of Diarrhea Caused by Antibiotics — May 8, 2012

Probiotics are believed to improve health by maintaining a normal balance of microorganisms in the human intestines. Evidence shows that they can reduce the risk of developing diarrhea, which is a common side effect of taking antibiotics.

My RAND ?

Saved Items

Recommended